Evidence map›Paper›PMID 24431230›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2014

Heterotropic modulation of selectin affinity by allosteric antibodies affects leukocyte rolling.

Sebastian B Riese, Christian Kuehne, Thomas F Tedder, Rupert Hallmann, Erhard Hohenester, Konrad Buscher

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 3 countries.

Sebastian B RieseInstitute of Laboratory Medicine, Clinical Chemistry and Pathobiochemistry, Charité-University of Medicine Berlin, 10117 Berlin, Germany;
Christian Kuehne
Thomas F Tedder
Rupert Hallmann
Erhard Hohenester
Konrad Buscher
Charité - Universitätsmedizin Berlin · DEDuke University Hospital · USImperial College London · GBPhysiological Society · GBUniversity Hospital Münster · DE

Funding

Wellcome Trust 083942Wellcome Trust 083942/Z/07/Z
6 · The paper itself

Abstract

Selectins are a family of adhesion receptors designed for efficient leukocyte tethering to the endothelium under shear. As a key property to resist premature bond disruption, selectin adhesiveness is enhanced by tensile forces that promote the conversion of a bent into an extended conformation of the N-terminal lectin and epidermal growth factor-like domains. Conformation-specific Abs have been invaluable in deciphering the activation mechanism of integrins, but similar reagents are not available for selectins. In this study, we show that the anti-human L-selectin mAbs DREG-55 and LAM1-5 but not DREG-56, DREG-200, or LAM1-1 heterotropically modulate adhesion presumably by stabilizing the extended receptor conformation. Force-free affinity assays, flow chamber, and microkinetic studies reveal a ligand-specific modulation of L-selectin affinity by DREG-55 mAb, resulting in a dramatic decrease of rolling velocity under flow. Furthermore, secondary tethering of polymorphonuclear cells was blocked by DREG-200 but significantly boosted by DREG-55 mAb. The results emphasize the need for a new classification for selectin Abs and introduce the new concept of heterotropic modulation of receptor function.

Indexed as

Amino Acid SequenceAntibodiesAntibodies, MonoclonalCell AdhesionCell LineHumansJurkat CellsLeukocyte RollingNeutrophilsSelectinsSequence AlignmentAntibodiesAntibodies, MonoclonalSelectins

Identifiers

PMID24431230
PMCPMC3921101
OpenAlexW2112717659

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.